在严重喘中向生物疗法:机制,生物标志物和临床应用
Renata Maria Văruț1, Dop Dalia2, Kristina Radivojevic1
1Research Methodology Department, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Pharmaceuticals (Basel, Switzerland)
|July 30, 2025
概括
严重的喘涉及复杂的炎症,有针对性的生物疗法,如抗IgE和抗细胞因子 (IL-5,IL-33,IL-4/IL-13) 抗体,改善了患者的治疗结果. 个性化治疗选择是有效控制喘的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种复杂的炎症性呼吸道疾病,由IL-4,IL-5,IL-13,IL-17和IL-33等细胞因子驱动.
- 过敏敏感性显著导致呼吸道过敏反应和喘患者的重塑.
- 生物标志物,如IgE,埃索诺菲尔和氧化,有助于对喘表型进行分类.
研究的目的:
- 审查当前严重喘的生物疗法.
- 讨论细胞因子和生物标志物在喘病原和治疗中的作用.
- 突出个性化医疗在治疗严重喘方面的重要性.
主要方法:
- 关于喘病原和生物治疗的科学文献的综述.
- 对针对特定细胞因子和IgE的单克隆抗体的临床试验数据的分析.
- 基于亲和力,剂量和疗效的生物制剂的比较.
主要成果:
- 针对IgE (奥马利祖马布) 和IL-5 (梅波利祖马布等) 的单克隆抗体. 减少恶化并改善肺功能.
- 像德佩莫基马布这样的新药提供了延长的剂量间隔.
- 抗IL-33 (伊特佩基马布) 和抗IL-4/IL-13 (特拉洛基努马布等) 的药物. 这些疗法在缓解eosinophilic炎症方面表现有前途.
结论:
- 生物疗法在治疗严重喘方面取得了重大进展.
- 以生物标志物为指导的个性化治疗策略对于优化患者的治疗结果至关重要.
- 持续的研究和比较分析对于完善严重喘管理至关重要.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
01:19Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
389
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
389
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K